Inget foto på Marja-Liisa Karjalainen-Lindsberg

Marja-Liisa Karjalainen-Lindsberg

  • Finland

20082019
Om du gjort några ändringar i Pure kommer de visas här snart.

Publikationer 2008 2019

Filter
Mötesabstrakt
2017

High Amount of PD-L1+Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

Pollari, M., Bruck, O., Leivonen, S-K., Pellinen, T., Vahamurto, P., Karjalainen-Lindsberg, M-L., Mannisto, S., Kellokumpu-Lehtinen, P-L., Mustjoki, S. & Leppa, S., 7 dec 2017, I : Blood. 130, Suppl 1, s. Meeting Abstract: 2761 2 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Low Expression of T/NK-Cell Signature Predicts Poor Survival in Patients with Primary Testicular and Diffuse Large B-Cell Lymphoma

Leivonen, S-K., Pollari, M., Bruck, O., Pellinen, T., Karjalainen-Lindsberg, M-L., Mannisto, S., Kellokumpu-Lehtinen, P-L., Mustjoki, S. & Leppa, S., 7 dec 2017, I : Blood. 130, 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2016

Dose-Dense Chemoimmunotherapy Including Early CNS Prophylaxis for High-Risk DLBCL. -Final Analysis from a Nordic Phase II Study (the CHIC trial)

Leppa, S., Joergensen, J., Tierens, A., Ostlie, I., Fagerli, U. M., Brown, P. D. N., Larsen, T. S., Mannisto, S., Munksgaard, L., Maisenholder, M., Vasala, K., Meyer, P., Jerkeman, M., Bjorkholm, M., Fluge, O., Jyrkkio, S., Ralfkiaer, E., Spetalen, S., Karjalainen-Lindsberg, M-L. & Holte, H., 2 dec 2016, I : Blood. 128, 22, 6 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Impact of Rituximab and Methotrexate on the Survival of the Patients with Sinonasal Tract Diffuse Large B-Cell Lymphoma

Vahamurto, P., Mannisto, S., Pollari, M., Karjalainen-Lindsberg, M-L., Makitie, A. A. & Leppa, S., 2 dec 2016, I : Blood. 128, 22, 6 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Integrative Genetic and Clinical Analysis through Whole Exome Sequencing in 1001 Diffuse Large B Cell Lymphoma (DLBCL) Patients Reveals Novel Disease Drivers and Risk Groups

Zhang, J., Reddy, A., Love, C., Moffitt, A. B., Rajagopalan, D., Leppa, S., Pasanen, A., Meriranta, L., Karjalainen-Lindsberg, M-L., Norgaard, P. H., Pederson, M., Gang, A. O., Hogdall, E., Richards, K. L., Fedoriw, Y. D., Bernal-Mizrachi, L., Koff, J. L., Staton, A. D., Flowers, C., Paltiel-Clarfield, O. & 23 andra, Goldschmidt, N., Calaminici, M., Clear, A. J., Gribben, J., Nguyen, E., Czader, M., Ondrejka, S. L., Collie, A., Hsi, E. D., Au-Yeung, R., Yok-Lam, K., Choi, W. L., Srivastava, G., Evens, A. M., Pilichowska, M., Sengar, M., Reddy, N., Li, S., Jaffe, E. S., Tzeng, T., Datta, J., Dunson, D. & Dave, S., 2 dec 2016, I : Blood. 128, 22, 6 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2014

Characterization of the Microrna Expression Profiles of Paired Primary and Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) By Next-Generation Sequencing

Leivonen, S-K., Icay, K., Liu, C., Taskinen, M., Lehtonen, R., Karjalainen-Lindsberg, M-L., Delabie, J., Holte, H., Hautaniemi, S. & Leppa, S., 6 dec 2014, I : Blood. 124, 21, 3 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

Somatic Mutations in E3 Ubiquitin Ligase Deltex 1 Are Associated with Survival in Diffuse Large B-Cell Lymphoma

Taskinen, M., Meriranta, L., Pasanen, A., Louhimo, R., Cervera, A., Karjalainen-Lindsberg, M-L., Holte, H., Delabie, J., Lehtonen, R., Hautaniemi, S. & Leppa, S., 6 dec 2014, I : Blood. 124, 21, 3 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2013

Global Profiling Of Outcome Associated Alternative Splicing Events and Gene Expression In Diffuse Large B-Cell Lymphoma

Taskinen, M., Chen, P., Karjalainen-Lindsberg, M-L., Cervera, A., Delabie, J., Holte, H., Hautaniemi, S. & Leppae, S., 15 nov 2013, I : Blood. 122, 21, 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2012

Use of exon-based transcriptome profiling to identify novel signaling pathways and survival-associated genes in diffuse large B-cell lymphoma

Leppa, S., Taskinen, M., Koivula, S., Chen, P., Louhimo, R., Delabie, J., Karjalainen-Lindsberg, M-L., Bjorkholm, M., Fluge, O., Pedersen, L. M., Rydstrom, K., Jerkeman, M., Eriksson, M., Hautaniemi, S., Holte, H. & Nordic Lymphoma Grp, 20 maj 2012, I : Journal of Clinical Oncology. 30, 15, 1 s., Meeting Abstract: 8074.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2011

Addition of Rituximab to Chemotherapy Alters the Prognostic Impact of Tumor-Associated Macrophages in Diffuse Large B-Cell Lymphoma

Riihijarvi, S., Poyhonen, M., Taskinen, M., Karjalainen-Lindsberg, M-L. & Leppa, S., 18 nov 2011, I : Blood. 118, 21, s. 1139-1139 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

INTEGRATIVE GENOMIC PROFILING OF HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS LESS THAN 65 YEARS OLD TREATED WITH DOSE-DENSE CHEMOIMMUNOTHERAPY AND CNS PROPHYLAXIS

Koivula, S., Taskinen, M., Louhimo, R., Chen, P., Delabie, J., Holte, H., Karjalainen-Lindsberg, M., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S. & Leppa, S., jun 2011, I : Annals of Oncology. 22, s. 207-207 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2010

Exon-Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B-Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose-Dense Chemoimmuno-therapy and CNS Prophylaxis. Results From a Nordic Lymphoma Group Phase II Study.

Koivula, S., Taskinen, M., Chen, P., Holte, H., Delabie, J., Karjalainen-Lindsberg, M-L., Bjorkholm, M., Fluge, O., Pedersen, L. M., Jerkeman, M., Eriksson, M., Hautaniemi, S. & Leppa, S., 19 nov 2010, I : Blood. 116, 21, s. 1281-1281 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years

Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M-L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Pedersen, L. M., Anderson, H., Jerkeman, M. & Eriksson, M., 19 nov 2010, I : Blood. 116, 21, s. 1157-1157 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

2008

Prognostic influence of tumor-infiltrating mast cells in follicular lymphoma patients treated with rituximab and CHOP

Taskinen, M., Karjalainen-Lindsberg, M. & Leppa, S., jun 2008, I : Annals of Oncology. 19, s. 178-178 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review

R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.

Holte, H., Leppa, S. M., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M-L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstroem, M., Moller-Pedersen, L., Anderson, H., Jerkeman, M. & Eriksson, M., 16 nov 2008, I : Blood. 112, 11, s. 1233-1233 1 s.

Forskningsoutput: TidskriftsbidragMötesabstraktForskningPeer review